share_log

BRIEF-ImmunoCellular Therapeutics Says Has Been Exploring Strategic Opportunities

路透社 ·  Aug 14, 2018 04:15
Aug 13 (Reuters) - ImmunoCellular Therapeutics Ltd :
   * IMMUNOCELLULAR THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS
   * Q2 LOSS PER SHARE $0.01
   * ONGOING EXPLORATION OF STRATEGIC OPPORTUNITIES
   * CONTINUED PROGRESS IN STEM-TO-T-CELL PROGRAM

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment